The Cigna Group (NYSE:CI) Shares Purchased by Fiduciary Financial Group LLC

Fiduciary Financial Group LLC lifted its holdings in The Cigna Group (NYSE:CIFree Report) by 8.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,247 shares of the health services provider’s stock after purchasing an additional 95 shares during the quarter. Fiduciary Financial Group LLC’s holdings in The Cigna Group were worth $348,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Rosenberg Matthew Hamilton increased its stake in shares of The Cigna Group by 29.1% in the 4th quarter. Rosenberg Matthew Hamilton now owns 687 shares of the health services provider’s stock valued at $190,000 after purchasing an additional 155 shares in the last quarter. Greenfield Savings Bank increased its stake in shares of The Cigna Group by 28.2% in the 4th quarter. Greenfield Savings Bank now owns 2,578 shares of the health services provider’s stock valued at $712,000 after purchasing an additional 567 shares in the last quarter. Miracle Mile Advisors LLC increased its stake in shares of The Cigna Group by 0.6% in the 4th quarter. Miracle Mile Advisors LLC now owns 16,681 shares of the health services provider’s stock valued at $4,606,000 after purchasing an additional 105 shares in the last quarter. Wedmont Private Capital increased its stake in shares of The Cigna Group by 8.7% in the 4th quarter. Wedmont Private Capital now owns 4,664 shares of the health services provider’s stock valued at $1,301,000 after purchasing an additional 373 shares in the last quarter. Finally, Trust Co. of Toledo NA OH increased its stake in shares of The Cigna Group by 6.2% in the 4th quarter. Trust Co. of Toledo NA OH now owns 1,032 shares of the health services provider’s stock valued at $285,000 after purchasing an additional 60 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Stock Performance

Shares of CI stock opened at $284.95 on Wednesday. The company’s fifty day moving average price is $303.49 and its two-hundred day moving average price is $327.70. The firm has a market capitalization of $79.26 billion, a P/E ratio of 26.88, a P/E/G ratio of 0.88 and a beta of 0.54. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $7.51 earnings per share for the quarter, beating analysts’ consensus estimates of $7.22 by $0.29. The business had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. The Cigna Group had a net margin of 1.31% and a return on equity of 18.42%. The company’s revenue for the quarter was up 29.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.77 EPS. On average, research analysts anticipate that The Cigna Group will post 28.5 earnings per share for the current fiscal year.

The Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 19th. Investors of record on Wednesday, December 4th were issued a dividend of $1.40 per share. This represents a $5.60 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date was Wednesday, December 4th. The Cigna Group’s payout ratio is 52.83%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $400.00 price objective on shares of The Cigna Group in a research note on Wednesday, October 23rd. Truist Financial cut their price objective on The Cigna Group from $420.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft lowered their target price on The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a report on Monday, November 4th. Piper Sandler restated an “overweight” rating and set a $394.00 target price (up from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. Finally, Royal Bank of Canada lowered their target price on The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. One analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $395.93.

Check Out Our Latest Stock Report on The Cigna Group

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.